TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Senate Passes NIH Reauthorization 87-10; $2.5 Bil. Auhtority For NCI, New Line Items April 10, 1992
TCL Archive Early, Short Course Of Hormonal Therapy May Allow Patients To Live Longer January 25, 2008